Anchorage, AK 的 乳癌 臨床試驗
7 項針對 乳癌 的研究正在 Anchorage（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
招募中3 期
- Alaska Oncology and Hematology LLC, Anchorage
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Anchorage Associates in Radiation Medicine, Anchorage
- Alaska Breast Care and Surgery LLC, Anchorage
- Alaska Oncology and Hematology LLC, Anchorage
- 還有 3 項
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- Alaska Oncology and Hematology, Anchorage
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- Anchorage Associates in Radiation Medicine, Anchorage
- Alaska Breast Care and Surgery LLC, Anchorage
- Alaska Oncology and Hematology LLC, Anchorage
- 還有 3 項
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
招募中
- Alaska Native Medical Center (ANMC), Anchorage
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
招募中觀察性研究
- Katmai Oncology Group - Anchorage, Anchorage
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
招募中觀察性研究
- Providence Alaska Medical Center, Anchorage
其他城市的 乳癌 試驗
- New York City, NY136 項研究
- Houston, TX126 項研究
- Boston, MA112 項研究
- Nashville, TN81 項研究
- Los Angeles, CA73 項研究
- Edison, NJ68 項研究
- St. Louis, MO64 項研究
- Queens, NY64 項研究
- Durham, NC64 項研究
- Chicago, IL59 項研究
- Philadelphia, PA56 項研究
- Dallas, TX55 項研究
Anchorage 的其他研究
- 非小細胞肺癌8 項研究
- 卵巢癌7 項研究
- 肺癌6 項研究
- 前列腺癌4 項研究
- 胰臟癌4 項研究
- 子宮內膜癌4 項研究
- 胃癌3 項研究
- 食道癌3 項研究
- 癌症（所有類型）3 項研究
- 急性雙表型白血病3 項研究
- 大腸直腸癌3 項研究
- 黑色素瘤3 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。